Tranexamic acid in orthopedic surgery;Ácido tranexámico en cirugía ortopédica

Revista Espanola de Cirugia Ortopedica y Traumatologia

Volumn 58, Issue 1, 2014, Pages 52-56

  Aguilera Roig, X ^a   Jordan Sales M ^a   Natera Cisneros, L ^a   Monllau Garcia J C ^a   Martinez Zapata M J ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Alternatives to transfusion; Prosthetic surgery; Tranexamic acid; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

BLOOD LOSS, SURGICAL; HUMAN; ORTHOPEDIC SURGERY;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; HUMANS; ORTHOPEDIC PROCEDURES; TRANEXAMIC ACID;

EID: 84892483276     PISSN: 18884415     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.recot.2013.08.005     Document Type: Short Survey

References (53)

1. Urban M.K. Anestesia para la cirugía ortopédica. Miller's Anesthesia 2010, Elsevier. R.D. Miller (Ed.).
2. Saleh KJ, Santos ER, Ghomrawi HM, Parvizi J, Mulhall KJ. Socieconomic issues and demographics in total knee arthroplasty revision. Clin Orthop Relat Res. 2006;446:15-21.
3. Paxton E.W., Furnes O., Namba R.S., Inacio M.C., Fenstad A.M., Havelin L.I. Comparison of the Norwegian knee arthroplasty register and a United States arthroplasty registry. J Bone Joint Surg Am 2011, 93:20-30.
4. Petäjä J., Myllynen P., Myllylä G., Vahtera E. Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scan 1987, 153:647-651.
5. Kalairajah Y., Simpson D., Cossey A.J., Verrall G.M., Spriggins A.J. Blood loss after total knee replacement: effects of computer-assisted surgery. J Bone Joint Surg (Br) 2005, 87:1480-1482.
6. Calvo R., Martínez-Zapata M.J., Urrútia G., Gich I., Jordán M., del Arco A., et al. Low-vs. high pressure suction drainage after total knee arthroplasty: A double blind randomized controlled trial. J Adv Nurs 2012, 68:758-766.
7. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4:CD002042.
8. Salido J.A., Marín L.A., Gómez L.A., Zorrilla P., Martínez C. Preoperative haemoglobin levels and the need for transfusion alter prosthetic hip and knee surgery: Analysis of predictive factors. J bone Joint Surg (Am) 2002, 84:216-220.
9. Spahn D.R., Moch H., Hofmann A., Isbister J.P. Patient blood management: The pragmatic solution for the problems with blood transfusions. Anesthesiology 2008, 109:951-953.
10. Nielsen H.J. Detrimental effects of perioperative blood transfusion. Br J Surg 1995, 82:582-587.
11. Kozek-Langenecker S.A., Afshari A., Albaladejo P., Santullano C.A., de Robertis E., Filipescu D.C., et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anesthesiol 2013, 30:270-382.
12. Frank S.M., Savage W.J., Rothschild J.A., Rivers R.J., Ness P.M., Paul S.L., et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 2012, 117:99-106.
13. Dunn C.J., Goa K.L. Tranexamic acid. A review of its use in surgery and other indications. Drugs 1999, 57:1005-1032.
14. De la Puerta E. Farmacoterapia para la reducción del sangrado perioperatorio. Medicina transfusional perioperatoria 2005, Ergon, Madrid. A.I. Diez Lobo (Ed.).
15. O'Brien J.G., Batisttini B., Zaharia F., Plante G.E., Sirois P. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats. Inflammation 2000, 24:411-429.
16. Agencia Española del Medicamento y Productos Sanitarios. Ácido tranexámico (AMCHAFIBRIN), ficha técnica revisada en diciembre de 2012 [consultado 26 Ago 2013]. Disponible en: http://aemps.es/cima/especialidad.do%3Fmetodo=verFichaWordPdf%26codigo=53939%26formato=pdf%26formulario=FICHAS%26file=ficha.pdf.
17. Bonnar J., Sheppard B.L. Treatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996, 313:579-582.
18. Athanasiadis T., Beule A.G., Wormald P.J. Effects of topical antifibrinolytics in endoscopic sinus surgery: A pilot randomized controlled trial. Am J Rhinol 2007, 21:737-742.
19. Sekhavat L., Tabatabaii A., Dalili M., Farajkhoda T., Tafti A.D. Efficacy of tranexamic acid reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009, 22:72-75.
20. Carter G., Goss A., Lloyd J., Tocchetti R. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: Randomised prospective clinical study. J Oral Maxillofac Surg 2003, 61:1432-1435.
21. Abrishami A., Chung F., Wong J. Topical application of antifibrinolytic drugs for on-pump cardiac surgery: A systematic review and meta-analysis. Can J Anaesth 2009, 56:202-212.
22. Tranexamic acid for unilateral total knee arthroplasty (TRANEXTOP). Última modificación en diciembre de 2012 [consultado 26 Ago 2013]. Disponible en: http://clinicaltrials.gov/ct2/show/NCT01594671%3Fterm=Tranexamic%26rank=4.
23. Eriksson O., Kjellman H., Pilbrant A., Schannong M. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers. Eur J Clin Pharmacol 1974, 7:375-380.
24. Anderson L., Nilsson I.M., Nihehn J.E., Hedner U., Granstrand B., Melander B. Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminoethyl cyclohexane carboxylic acid. Scand J Haematol 1965, 2:230-247.
25. Isseta C., Susen S., Charpentier F., May M.A., Albadalejo P. Comment prévenit et tratiter les complications hémorragiques induites par certains AAP per- et postopératoires?. Agents antiplaquetaires et période périopératoire. (Conférence d'experts). La collection de la SFAR 2002, Éditions scientifiques et médicales Elsevier SAS, París.
26. Ahlberg A., Eriksson O., Kjellman H. Diffusion of tranexamic acid to the joint. Acta Orthop Scand 1976, 47:486-488.
27. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 trial collaborators.
28. Benoni G., Fredin H., Knebel R., Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: A randomized, double-blind study in 40 primary operations. Acta Orthop Scand 2001, 72:442-448.
29. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005, 87:766-770.
30. Rajesparan K., Biant L.C., Ahmad M., Field R.E. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009, 91:776-783.
31. Ho K.M., Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty. A meta-analysis. Anaesth Intensive Care 2003, 31:529-537.
32. Brian J., Chase E., Rosenstein A.D. The use of tranexamic acid in revision total hip arthroplasty: A pilot study. Curr Orthop Prac 2009, 20:152-156.
33. Yamasaki S., Masuhara K., Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty-prospective randomized study in 40 cases. Int Orthop 2004, 28:69-73.
34. Alvarez J.C., Santiveri F.X., Ramos I., Vela E., Puig L., Escolano F. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008, 48:519-525.
35. Good L., Peterson E., Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. B J Anaesth 2003, 90:595-599.
36. Aguilera X., Videla S., Almenara M., Fernandez J.A., Gich I., Celaya F. Effectiveness of tranexamic acid in revision total knee arthroplasty. Acta Ortopedica Belga 2012, 78:68-74.
37. Neilipovitz D.T., Murto K., Hall L., Barrowman N.J., Splinter W.M. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anaesth Analg 2001, 93:82-87.
38. Sethna N.F., Zurakowski D., Brustowicz R.M., Bacsik J., Lorna J., Sullivan, et al. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anaesthesiology 2005, 102:727-732.
39. Kagoma Y.K., Crowther M.A., Douketis J., Bhandari M., Eikelboom J., Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials. Thromb Res 2009, 123:687-696.
40. Lozano M., Basora M., Peidro L., Merino I., Segur J.M., Pereira A., et al. Effectiveness and safety of tranexamic acid administration during total knee arthroplasty. Vox Sang 2008, 95:39-44.
41. Cid J., Lozano M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthoplasty: results of a meta-analysis of randomized controlled trials. Transfusion 2005, 45:1302-1307.
42. Henry D.A., Carless P.A., Moxey A.J., O'Connell D., Stokes B.J., Fergusson D.A., et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011, CD001886.
43. Wong J., Abrishami A., el Beheiry H., Mahomed N.N., Roderick Davey J., Gandhi R., et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: A randomized, controlled trial. J Bone Joint Surg Am 2010, 92:2503-2513.
44. Ishida K., Tsumura N., Kitagawa A., Hamamura S., Fukuda K., Dogaki Y., et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011, 35:1639-1645.
45. Sa-Ngasoongsong P., Channoom T., Kawinwonggowit V., Woratanarat P., Chanplakorn P., Wibulpolprasert B., et al. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Orthop Rev 2011, 3:51-56.
46. Mutsuzaki H., Ikeda K. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res 2012, 7:32.
47. Leal-Noval S.R., Muñoz M., Asuero M., Contreras E., García-Erce J.A., Llau J.V., et al. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla. Rev Esp Anestesiol Reanim 2013, 60:263.e1-263.e25.
48. Roberts I., Perel P., Prieto-Merino D., Shakur H., Coats T., Hunt B.J., et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: Prespecified analysis of data from randomised controlled trial. BMJ 2012, 11:345-352.
49. Yang Z.-G., Chen W.-P., Wu L.-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-Analysis. J Bone Joint Surg Am 2012, 94:1153-1159.
50. Hutton B., Joseph L., Fergusson D., Mazer D., Shapiro S., Tinmouth A. Risks of harms using antifibrinolytics in cardiac surgery: Systematic review and network meta-analysis of randomised and observational studies. BMJ 2012, 345:e5798. 10.1136/bmj.e5798.
51. Vigna-Taglianti F., Basso L., Rolfo P., Brambilla R., Vaccari F., Lanci G., et al. Tranexamic acid for reducing blood transfusions in arthroplasty interventions: A cost-effective practice. Eur J Orthop Surg Traumatol 2013, [Epub ahead of print] PMID: 23633085.
52. Irisson E., Hémon Y., Pauly V., Parratte S., Argenson J.N., Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip andknee replacement surgery. Orthop Traumatol Surg Res 2012, 98:477-483.
53. Gillette B.P., Maradit Kremers H., Duncan C.M., Smith H.M., Trousdale R.T., Pagnano M.W., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013, pii: S0883-5403(13)00491-9. 10.1016/j.arth.2013.04.054.